UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended June 30, 2004

 

 

 

OR

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 001-13279

 

UNOVA, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

95-4647021

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

 

 

6001 36th Avenue West
Everett, WA
www.unova.com

 

98203-1264

(Address of principal executive
offices and internet site)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (425) 265-2400

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes ý  No o

 

On July 30, 2004 there were 60,870,065 shares of Common Stock outstanding, exclusive of treasury shares.

 

 



 

UNOVA, INC.

 

INDEX

 

REPORT ON FORM 10-Q

 

FOR THE QUARTER ENDED JUNE 30, 2004

 

PART I.  FINANCIAL INFORMATION

 

 

 

 

 

ITEM 1.

Financial Statements

 

 

 

 

 

 

Consolidated Statements of Operations
Six Months Ended June 30, 2004 and 2003 (unaudited)

 

 

 

 

 

 

Consolidated Statements of Operations
Three Months Ended June 30, 2004 and 2003 (unaudited)

 

 

 

 

 

 

Consolidated Balance Sheets
June 30, 2004 and December 31, 2003 (unaudited)

 

 

 

 

 

 

Consolidated Statements of Cash Flows
Six Months Ended June 30, 2004 and 2003 (unaudited)

 

 

 

 

 

 

Notes to Consolidated Financial Statements (unaudited)

 

 

 

 

 

ITEM 2.

Management’s Discussion and Analysis of
Financial Condition and Results of Operations

 

 

 

 

 

ITEM 3.

Quantitative and Qualitative Disclosures about Market Risk

 

 

 

 

 

ITEM 4.

Controls and Procedures

 

 

 

 

PART II.  OTHER INFORMATION

 

 

 

 

ITEM 2.

Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities

 

 

 

 

 

ITEM 4.

Submission of Matters to a Vote of Security Holders

 

 

 

 

 

ITEM 6.

Exhibits and Reports on Form 8-K

 

 

 

 

Signature

 

 



 

PART I.  FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

UNOVA, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

(amounts in thousands, except per share amounts)

(unaudited)

 

 

 

Six Months Ended
June 30,

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Sales and Service Revenues:

 

 

 

 

 

Sales revenues

 

$

546,590

 

$

486,471

 

Service revenues

 

55,293

 

57,239

 

Total Sales and Service Revenues

 

601,883

 

543,710

 

 

 

 

 

 

 

Costs and Expenses:

 

 

 

 

 

Cost of sales

 

365,452

 

341,992

 

Cost of service

 

36,793

 

37,389

 

Selling, general and administrative

 

158,055

 

149,554

 

Depreciation and amortization

 

9,394

 

13,402

 

Special charges

 

642

 

1,945

 

 

 

 

 

 

 

Total Costs and Expenses

 

570,336

 

544,282

 

 

 

 

 

 

 

Operating Profit (Loss) from Continuing Operations

 

31,547

 

(572

)

 

 

 

 

 

 

Interest, net

 

(6,254

)

(7,039

)

Earnings (Loss) from Continuing Operations before Income Taxes

 

25,293

 

(7,611

)

Provision for Income Taxes

 

(9,084

)

(4,200

)

Earnings (Loss) from Continuing Operations, Net of Tax

 

16,209

 

(11,811

)

Loss from Discontinued Operations, Net of Tax

 

(115

)

(3,872

)

 

 

 

 

 

 

Net Earnings (Loss)

 

$

16,094

 

$

(15,683

)

 

 

 

 

 

 

Basic Earnings (Loss) per Share

 

 

 

 

 

Continuing Operations

 

$

0.27

 

$

(0.20

)

Discontinued Operations

 

(0.00

)

(0.07

)

Net Earnings (Loss) per Share

 

$

0.27

 

$

(0.27

)

 

 

 

 

 

 

Diluted Earnings (Loss) per Share

 

 

 

 

 

Continuing Operations

 

$

0.26

 

$

(0.20

)

Discontinued Operations

 

(0.00

)

(0.07

)

Net Earnings (Loss) per Share

 

$

0.26

 

$

(0.27

)

 

 

 

 

 

 

Shares Used in Computing Basic Earnings (Loss) per Share

 

60,296

 

58,444

 

 

 

 

 

 

 

Shares Used in Computing Diluted Earnings (Loss) per Share

 

62,069

 

58,444

 

 

See accompanying notes to consolidated financial statements.

 

1



 

UNOVA, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(amounts in thousands, except per share amounts)
(unaudited)

 

 

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Sales and Service Revenues:

 

 

 

 

 

Sales revenues

 

$

277,413

 

$

249,947

 

Service revenues

 

26,800

 

29,755

 

Total Sales and Service Revenues

 

304,213

 

279,702

 

 

 

 

 

 

 

Costs and Expenses:

 

 

 

 

 

Cost of sales

 

189,433

 

173,249

 

Cost of service

 

17,856

 

18,968

 

Selling, general and administrative

 

79,404

 

73,274

 

Depreciation and amortization

 

4,610

 

6,618

 

Special charges

 

259

 

947

 

 

 

 

 

 

 

Total Costs and Expenses

 

291,562

 

273,056

 

 

 

 

 

 

 

Operating Profit from Continuing Operations

 

12,651

 

6,646

 

 

 

 

 

 

 

Interest, net

 

(3,186

)

(3,177

)

Earnings from Continuing Operations before Income Taxes

 

9,465

 

3,469

 

Provision for Income Taxes

 

(3,768

)

(2,600

)

Earnings from Continuing Operations, Net of Tax

 

5,697

 

869

 

Loss from Discontinued Operations, Net of Tax

 

(85

)

(1,669

)

 

 

 

 

 

 

Net Earnings (Loss)

 

$

5,612

 

$

(800

)

 

 

 

 

 

 

Basic Earnings (Loss) per Share

 

 

 

 

 

Continuing Operations

 

$

0.09

 

$

0.02

 

Discontinued Operations

 

(0.00

)

(0.03

)

Net Earnings (Loss) per Share

 

$

0.09

 

$

(0.01

)

 

 

 

 

 

 

Diluted Earnings (Loss) per Share

 

 

 

 

 

Continuing Operations

 

$

0.09

 

$

0.02

 

Discontinued Operations

 

(0.00

)

(0.03

)

Net Earnings (Loss) per Share

 

$

0.09

 

$

(0.01

)

 

 

 

 

 

 

Shares Used in Computing Basic Earnings (Loss) per Share

 

60,403

 

58,474

 

 

 

 

 

 

 

Shares Used in Computing Diluted Earnings (Loss) per Share

 

62,011

 

59,661

 

 

See accompanying notes to consolidated financial statements.

 

2



 

UNOVA, INC.
CONSOLIDATED BALANCE SHEETS
(amounts in thousands)
(unaudited)

 

 

 

June 30,
2004

 

December 31, 2003

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash and cash equivalents

 

$

191,070

 

$

238,447

 

Accounts receivable, net of allowance for doubtful accounts of $15,725, 2004 and $21,964, 2003

 

320,659

 

275,594

 

Inventories, net of progress billings

 

157,874

 

132,324

 

Deferred tax assets

 

65,424

 

71,229

 

Assets held for sale

 

19,681

 

23,840

 

Other current assets

 

17,071

 

19,513

 

Total Current Assets

 

771,779

 

760,947

 

 

 

 

 

 

 

Property, Plant and Equipment, Net of Accumulated Depreciation of $220,731, 2004 and $215,944, 2003

 

74,558

 

77,292

 

Goodwill and Other Intangibles, Net

 

75,015

 

75,639

 

Deferred Tax Assets

 

116,113

 

111,820

 

Other Assets

 

57,108

 

65,119

 

Total Assets

 

$

1,094,573

 

$

1,090,817

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ INVESTMENT

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

 

$

257,895

 

$

265,626

 

Payroll and related expenses

 

40,456

 

54,893

 

Current portion of long-term obligations

 

100,000

 

 

Total Current Liabilities

 

398,351

 

320,519

 

 

 

 

 

 

 

Long-term Obligations

 

108,500

 

208,500

 

Other Long-term Liabilities

 

134,930

 

130,970

 

 

 

 

 

 

 

Shareholders’ Investment:

 

 

 

 

 

Common stock

 

610

 

605

 

Additional paid-in capital

 

698,132

 

690,745

 

Accumulated deficit

 

(241,472

)

(257,566

)

Accumulated other comprehensive loss

 

(4,478

)

(2,956

)

Total Shareholders’ Investment

 

452,792

 

430,828

 

Total Liabilities and Shareholders’ Investment

 

$

1,094,573

 

$

1,090,817

 

 

See accompanying notes to consolidated financial statements.

 

3



 

UNOVA, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(amounts in thousands)
(unaudited)

 

 

 

Six Months Ended
June 30,

 

 

 

2004

 

2003

 

 

 

 

 

 

 

Cash and Cash Equivalents at Beginning of Period

 

$

238,447

 

$

178,269

 

 

 

 

 

 

 

Cash Flows from Operating Activities:

 

 

 

 

 

Net earnings (loss)

 

16,094

 

(15,683

)

Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

Depreciation and amortization

 

9,394

 

14,138

 

Change in prepaid and accrued pension costs, net

 

5,401

 

3,901

 

Deferred taxes

 

(1,081

)

(1,658

)

Special charges and other

 

(521)

 

(83)

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(41,755

)

54,045

 

Inventories

 

(25,619

)

277

 

Other current assets

 

2,387

 

(2,260

)

Accounts payable and accrued expenses

 

(4,435

)

(780

)

Payroll and related expenses

 

(14,282

)

(16,631

)

Other long-term liabilities

 

(114

)

189

 

Other operating activities

 

5,059

 

5,493

 

 

 

 

 

 

 

Net Cash Provided by (Used in) Operating Activities

 

(49,472

)

40,948

 

 

 

 

 

 

 

Cash Flows from Investing Activities:

 

 

 

 

 

Capital expenditures

 

(6,417

)

(7,814

)

Sale of property, plant and equipment

 

4,409

 

4,187

 

Other investing activities

 

(63

)

1,163

 

 

 

 

 

 

 

Net Cash Used in Investing Activities

 

(2,071

)

(2,464

)

 

 

 

 

 

 

Cash Flows from Financing Activities:

 

 

 

 

 

Stock Options exercised

 

2,774

 

879

 

Repayment of long-term obligations

 

 

(16,200

)

Other financing activities

 

1,392

 

1,549

 

 

 

 

 

 

 

Net Cash Provided by (Used in) Financing Activities

 

4,166

 

(13,772

)

 

 

 

 

 

 

Resulting Increase (Decrease) in Cash and Cash Equivalents

 

(47,377

)

24,712

 

 

 

 

 

 

 

Cash and Cash Equivalents at End of Period

 

$

191,070

 

$

202,981

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information:

 

 

 

 

 

Interest paid

 

$

(7,600

)

$

(8,185

)

Income taxes paid

 

$

(4,307

)

$

(4,152

)

 

See accompanying notes to consolidated financial statements.

 

4



 

UNOVA, INC.
NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

 

1.                          Basis of Presentation

 

UNOVA, Inc. and subsidiaries (“UNOVA” or the “Company”) is a global supplier of mobile computing and wireless network products for non-office applications and of manufacturing systems technologies primarily for the automotive and aerospace industries. The Company is headquartered in Everett, Washington and incorporated in the state of Delaware.

 

The amounts included in this report are unaudited; however, in the opinion of management, all adjustments necessary for a fair presentation of results of operations, financial position and cash flows for the stated periods have been included. These adjustments are of a normal recurring nature. Certain prior-year amounts have been reclassified to conform to current year presentation. These consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2003. The results of operations for the interim periods presented are not necessarily indicative of operating results for the entire year.

 

2.                          Stock-Based Compensation

 

As permitted by Statement of Financial Accounting Standards (“SFAS”) No. 123, the Company accounts for its stock-based compensation plans in accordance with Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees,” under which compensation cost is recognized over the vesting period if the fair value is greater than the exercise price (the intrinsic value method) at the grant of stock options. Had compensation cost for these plans been determined consistent with SFAS No. 123, “Accounting for Stock-Based Compensation,” the Company’s net earnings (loss) and basic and diluted earnings (loss) per share for the three and six months ended June 30, 2004, and 2003, would have been reduced (increased) to the pro forma amounts indicated in the following table (thousands of dollars):

 

 

 

Six Months Ended
June 30,

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Net earnings (loss) as reported

 

$

16,094

 

$

(15,683

)

$

5,612

 

$

(800

)

Add: stock-based compensation expense recorded under the intrinsic value method,. net of tax effect

 

513

 

588

 

340

 

375

 

Less: stock compensation expense computed under the fair value method, net of tax effect

 

(1,713

)

(2,292

)

(892

)

(1,203

)

Pro forma net earnings (loss)

 

$

14,894

 

$

(17,387

)

$

5,060

 

$

(1,628

)

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share as reported:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.27

 

$

(0.27

)

$

0.09

 

$

(0.01

)

Diluted

 

$

0.26

 

$

(0.27

)

$

0.09

 

$

(0.01

)

 

 

 

 

 

 

 

 

 

 

Pro forma earnings (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.25

 

$

(0.30

)

$

0.08

 

$

(0.03

)

Diluted

 

$

0.24

 

$

(0.30

)

$

0.08

 

$

(0.03

)

 

During the six months ended June 30, 2004, the Company issued 628,984 shares of Common Stock under its stock compensation plans, including 456,740 shares issued upon the exercise of options, 66,402 shares of restricted stock and 105,842 shares issued under the Employee Stock Purchase Plan and Directors Stock Option and Fee Plan. Also during the six months ended June 30, 2004, 80,212 shares of restricted stock vested due to completion of the vesting period.

 

5



 

3.                          Inventories, Net of Progress Billings

 

Inventories, net of progress billings, comprise the following (thousands of dollars):

 

 

 

June 30,
2004

 

December 31,
2003

 

Raw materials

 

$

88,288

 

$

89,085

 

Work in process

 

56,249

 

50,908

 

Finished goods

 

25,870

 

16,105

 

Less: progress billings

 

(12,533

)

(23,774

)

Inventories, net of progress billings

 

$

157,874

 

$

132,324

 

 

4.                          Long-term Obligations and Interest, net

 

The Company maintains two secured long-term credit facilities: a $100 million asset-based revolving credit facility (the “Revolving Facility”) and a £15.0 million ($27.4 million) revolving facility and related overdraft facility (collectively, the “UK Facility”).

 

Net of outstanding letters of credit and limitations on Minimum Availability, the Company had borrowing capacity at June 30, 2004, of $21.6 million under the Revolving Facility and £6.9 million ($12.5 million) under the UK Facility. The Company made no borrowings under the Revolving Facility or the UK Facility at any time during the first six months of 2004, and as of June 30, 2004, no borrowings were outstanding under either facility. As of June 30, 2004, the Company was in compliance with the financial covenants of each of these agreements. On July 9, 2004, the Revolving Facility was amended to extend its termination date to October 8, 2004.

 

In March 1998, the Company sold $200.0 million principal amount of senior unsecured debt in an underwritten offering. The debt comprised $100.0 million of 6.875% seven-year notes and $100.0 million of 7.00% ten-year notes. Interest payments are due semi-annually. Including underwriting fees, discounts and other issuance costs, the effective interest rates on the seven-year and ten-year notes are 7.125% and 7.175%, respectively. As of June 30, 2004, the $100.0 million seven-year notes, maturing in March 2005, are classified as current portion of long-term obligations on the Company’s consolidated balance sheet.

 

The Company additionally has outstanding $8.5 million of 3.21% industrial revenue bonds, maturing in July 2005.

 

Interest, net comprises the following (thousands of dollars):

 

 

 

Six Months Ended
June 30,

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Interest expense

 

$

8,139

 

$

8,706

 

$

4,130

 

$

4,065

 

Interest income

 

(1,885

)

(1,667

)

(944

)

(888

)

Interest, net

 

$

6,254

 

$

7,039

 

$

3,186

 

$

3,177

 

 

6



 

The Company also has letter-of-credit reimbursement agreements primarily related to the Company’s performance on contracts with customers totaling $34.7 million at June 30, 2004, compared to $35.9 million at December 31, 2003. The Company believes it is not practicable to estimate fair values of these instruments and considers the risk of non-performance on the contracts to be remote.

 

5.                          Special Charges and Restructuring Activities

 

Special charges comprise the following by reportable segment (thousands of dollars):

 

 

 

Six Months Ended
June 30,

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

IAS:

 

 

 

 

 

 

 

 

 

Facility consolidation

 

$

170

 

$

661

 

$

(130

)

$

568

 

Impairment of property, plant and equipment

 

83

 

 

 

 

Severance

 

 

641

 

 

17

 

Total IAS

 

253

 

1,302

 

(130

)

585

 

 

 

 

 

 

 

 

 

 

 

Corporate:

 

 

 

 

 

 

 

 

 

Facility consolidation

 

383

 

643

 

383

 

362

 

Severance

 

6

 

 

6

 

 

Total Corporate

 

389

 

643

 

389

 

362

 

Special charges

 

$

642

 

$

1,945

 

$

259

 

$

947

 

 

IAS Segment: The following table summarizes IAS restructuring activities during the six months ended June 30, 2004 (thousands of dollars):

 

 

 

Workforce
reduction

 

Consolidation of
facilities

 

Total

 

 

 

 

 

 

 

 

 

Accrual balance at December 31, 2003

 

$

6,008

 

$

1,129

 

$

7,137

 

Total charges

 

 

170

 

170

 

Cash payments

 

(3,703

)

(998

)

(4,701

)

Other

 

(35

)

308

 

273

 

Accrual balance at June 30, 2004

 

$

2,270

 

$

609

 

$

2,879

 

 

In the fourth quarter of 2002, as a result of the continued economic downturn in the global automotive, aerospace and heavy equipment industries, the Company initiated a plan to consolidate its Cincinnati Machine, Lamb Machining Systems and Lamb Body & Assembly Systems divisions into the new operating entity, Cincinnati Lamb. The plan included the relocation of certain Cincinnati Machine operations, outsourcing of certain manufacturing activities, termination of employees, and the sale of certain plant and equipment. This restructuring was substantially complete by December 31, 2003.

 

During the six months ended June 30, 2004, IAS recorded additional charges of $0.2 million for additional facility consolidation costs and $0.1 million for impairment of property, plant and equipment in conjunction with this plan. As of June 30, 2004, the IAS segment had terminated 793 employees and paid $20.0 million in severance, cumulatively, in conjunction with this plan. During the six months ended June 30, 2004, 109 employees were terminated and $3.7 million of severance was paid in conjunction with this plan. The number of employees terminated does not include 228 employees of Lamb Body & Assembly that are no longer IAS employees as a result of the divestiture of this operation in September 2003.

 

7



 

Corporate: During the third quarter of 2002, the Company initiated a plan to relocate its corporate office to its existing Intermec Technologies Corporation facility in Everett, Washington. This relocation was substantially complete by June 30, 2003. As of June 30, 2004, 22 employees had been terminated and $0.7 million in severance costs had been paid, cumulatively, of which 2 employee terminations and $0.3 million in severance payments occurred during the six months ended June 30, 2004. In the first quarter of 2004, $1.4 million of the workforce reduction accrual, relating to certain pension obligations for certain individuals affected by the restructuring plan, was reclassified to other long-term liabilities. The corporate restructuring accrual as of June 30, 2004, of $2.0 million relates to ongoing leased facility obligations. During the six months ended June 30, 2004, $1.0 million of leased facility costs were paid and during the six and three months ended June 30, 2004, the Company recognized $0.4 million of expense related to ongoing leased facility obligations.

 

6.                          Loss from Discontinued Operations, Net of Tax

 

During the third quarter of 2003, in conjunction with the consolidation plan described in Note 5, the Company sold substantially all the assets and existing backlog of its Lamb Body & Assembly Systems division. The Company received $12.8 million in 2003, and $2.5 million in April 2004, and retained $9.9 million in accounts payable. The division meets the definition of a “component of an entity” and has been accounted for as a discontinued operation under Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” (“SFAS No. 144”). The Company’s consolidated statement of operations for the six and three months ended June 30, 2003, have been restated to present this division as discontinued operations for comparative purposes.

 

Sales and service revenue from discontinued operations was $0.9 million for the six and three month periods ended June 30, 2004, compared with $22.1 million and $12.4 million, for the respective corresponding prior year periods. Losses from discontinued operations were $0.1 million for the six and three months ended June 30, 2004. The related tax effect from discontinued operations was $0.1 million for the six and three months ended June 30, 2004. Losses from discontinued operations were $3.9 million and $1.7 million for the six and three months ended June 30, 2003. Losses from discontinued operations did not have a tax effect for the six and three months ended June 30, 2003, as the Company’s domestic income tax benefit was offset by a corresponding valuation allowance.

 

The Company’s consolidated balance sheet as of June 30, 2004, includes $2.9 million in current assets, including $1.8 million of net property, plant and equipment classified as assets held for sale, $6.6 million in current liabilities, and $5.2 million in other long-term liabilities pertaining to discontinued operations. The Company’s consolidated balance sheet as of December 31, 2003, includes $3.7 million in current assets, including $1.8 million of assets held for sale, $7.0 million in current liabilities and $5.1 million in other long-term liabilities pertaining to discontinued operations.

 

7.                          Provision for Income Taxes

 

The provision for income taxes for the six and three months ended June 30, 2004, is primarily related to federal, state and foreign taxes. The provision for income taxes for the six and three months ended June 30, 2003, is primarily related to foreign and state taxes, as the domestic tax benefit was offset by a corresponding valuation allowance.

 

8



 

8.                          Earnings (Loss) per Share and Shareholders’ Investment

 

Basic earnings (loss) per share is calculated using the weighted average number of common shares outstanding and issuable for the applicable period. Diluted earnings per share is computed using basic weighted average shares plus the dilutive effect of unvested restricted stock and outstanding stock options using the “treasury stock” method.

 

 

 

Six Months Ended
June 30,

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Weighted average common shares - Basic

 

60,295,503

 

58,443,754

 

60,403,192

 

58,474,431

 

Dilutive effect of unvested restricted stock and stock options

 

1,773,173

 

 

 

1,608,045

 

1,186,286

 

Weighted average shares - Diluted

 

62,068,676

 

58,443,754

 

62,011,237

 

59,660,717

 

 

Because the Company reported a net loss from continuing operations for the six months ended June 30, 2003, stock options and unvested restricted stock are excluded from the diluted earnings per share computation as their effect would have been antidilutive. At June 30, 2003, Company employees and directors held options to purchase 5,831,194 shares of Company common stock. Also, Company employees held a weighted average of 446,786 unvested restricted shares for the six month period ended June 30, 2003.

 

9.                          Comprehensive Earnings (Loss)

 

The Company’s comprehensive earnings (loss) amounts comprise the following (thousands of dollars):

 

 

 

Six Months Ended
June 30,

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Net earnings (loss)

 

$

16,094

 

$

(15,683

)

$

5,612

 

$

(800

)

Change in equity due to foreign currency translation adjustments

 

(1,642

)

8,694

 

311

 

8,378

 

Unrealized gains on cash flow hedges

 

120

 

 

197

 

 

Comprehensive earnings (loss)

 

$

14,572

 

$

(6,989

)

$

6,120

 

$

7,578

 

 

10.                   Intellectual Property Settlements

 

During the first quarter of 2004, the Company received compensation in relation to one settlement regarding certain of its intellectual property. Additionally, the Company received compensation in relation to two IP settlements during the second quarter of 2003. The terms of these settlements are confidential. The operating profit from IP settlements, net of legal fees, for the six months ended June 30, 2004, and 2003, was $15.8 million and $4.6 million, respectively. Operating profit from IP settlements was $5.3 million for the three months ended June 30, 2003. IP settlement compensation is classified as sales revenues and the related legal costs are classified as cost of sales on the Company’s consolidated statements of income.

 

11.                   Segment Reporting

 

The Company has two reportable segments, Automated Data Systems (“ADS”) and Industrial Automation Systems (“IAS”).  Segments are determined principally on the basis of their products and services.  The ADS segment comprises the Company’s wholly owned subsidiary Intermec Technologies Corporation (“Intermec”). Intermec products and services include rugged mobile computing solutions, wireless, radio frequency identification (RFID) and automated data collection systems for field workers, on-premises and site-based workers as well as wireless network systems for untethered enablement of an enterprise, and barcode label and printing solutions. ADS’s rugged and robust systems, solutions and services enable Intermec’s customers to more

 

9



 

efficiently and effectively manage their supply chains and fulfillment activities. The IAS segment comprises the Cincinnati Lamb division and the Landis Grinding Systems division. IAS is a leading producer of value-added manufacturing technologies, products and services spanning the production cycle from process engineering and design to systems integration including comprehensive life cycle support. IAS serves primarily the global aerospace, automotive, off-road vehicle and diesel engine industries as well as industrial components, heavy equipment and general job shop markets.

 

Corporate and other amounts include corporate operating costs and foreign currency transaction gains and losses.  Intercompany transactions have been eliminated. The following table sets forth the Company’s operations by business segments (thousands dollars):

 

 

 

Six Months Ended
June 30,

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

 

 

 

 

 

 

 

 

 

 

Sales and Service Revenues

 

 

 

 

 

 

 

 

 

Automated Data Systems

 

$

379,584

 

$

341,922

 

$

186,579

 

$

179,040

 

Industrial Automation Systems

 

222,299

 

201,788

 

117,634

 

100,662

 

Total Sales and Service Revenues

 

$

601,883

 

$

543,710

 

$

304,213

 

$

279,702

 

 

 

 

 

 

 

 

 

 

 

Operating Profit (Loss) from Continuing Operations

 

 

 

 

 

 

 

 

 

Segment Operating Profit (Loss)

 

 

 

 

 

 

 

 

 

Automated Data Systems

 

$

43,645

 

$

30,497

 

$

15,599

 

$

21,495

 

Industrial Automation Systems

 

(2,242

)

(16,431

)

3,011

 

(8,235

)

Total Segment Operating Profit

 

41,403

 

14,066

 

18,610

 

13,260

 

 

 

 

 

 

 

 

 

 

 

Corporate and Other

 

(9,214

)

(12,693

)

(5,700

)

(5,667

)

Special Charges

 

(642

)

(1,945

)

(259

)

(947

)

Operating Profit (Loss) from Continuing Operations

 

$

31,547

 

$

(572

)

$

12,651

 

$

6,646

 

 

12.                   Related Party Transactions

 

An amount due from a non-executive officer of $0.2 million is included in other assets at June 30, 2004, and December 31, 2003.

 

Unitrin, Inc., a significant shareholder of the Company, owning approximately 21% of the Company’s outstanding common shares, and various of its subsidiaries (collectively, “Unitrin”) participated as a lender in the Term Loan. In January 2003, the Company paid off the remaining $16.2 million balance of the Term Loan, of which Unitrin had committed to and funded $6.8 million. Interest expense associated with amounts funded by Unitrin was $0.1 million for the six months ended June 30, 2003.

 

10



 

13.                   Commitments and Contingencies

 

Provisions for estimated expenses related to product warranties are made at the time products are sold. These estimates are established using historical information on the nature, frequency, and average cost of warranty claims. Management actively studies trends of warranty claims and takes action to improve product quality and minimize warranty claims. The following table indicates the change in the Company’s warranty accrual included in current liabilities (thousands of dollars):

 

 

 

Product Warranty
Liabilities

 

 

 

 

 

Beginning balance as of  January 1, 2004

 

$

27,139

 

Payments

 

(8,919

)

Increase in liability (new warranties issued)

 

6,318

 

Adjustments (pre-existing warranties)

 

115

 

Currency translation adjustment

 

194

 

Ending Balance as of June 30, 2004

 

$

24,847

 

 

The Company has entered into a variety of agreements with third parties that include indemnification clauses, both in the ordinary course of business and in connection with our divestitures of certain product lines.  These clauses require us to compensate these third parties for certain liabilities and damages incurred by them. FASB Interpretation No. 45, “Guarantors’ Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others” requires that the Company estimate and record the fair value of guarantees as a liability. The Company does not believe there is any significant exposure related to such guarantees and therefore has not recorded a liability as of June 30, 2004, and December 31, 2003.  The Company has not made any significant indemnification payments as a result of these clauses, nor does it believe the fair value of any of these guarantees has a material effect on the Company’s financial position or results of operations.

 

The Company is currently, and is from time to time, subject to claims and suits arising in the ordinary course of its business. In the opinion of the Company’s General Counsel, the ultimate resolution of currently pending proceedings, with the potential exception of one case discussed below, will not have a material adverse effect on the Company’s consolidated financial statements.

 

Tower Automotive Products Co. v. Lamb Technicon Body and Assembly is a lawsuit filed on March 11, 2002 in the Kent County Circuit Court in Michigan, generally alleging a breach of contract and warranty involving a frame assembly production line. The Company has responded to the Complaint. A trial date has been scheduled for the first quarter of 2005. Management believes the lawsuit is without merit and is vigorously contesting the case. Nevertheless, should there be an unfavorable result it is possible that cash flows or results of operations could be materially affected in that period or subsequent periods.

 

14.                   Pension and Other Postretirement Benefit Plans.

 

The following represents the net periodic pension and post-retirement benefit costs and related components in accordance with SFAS 132(R) as described in Note 15:

 

Components of Net Pension and Postretirement Periodic Benefit Cost for the six and three months ended June 30, 2004 and 2003 are as follows (thousands of dollars):

 

11



 

 

 

U.S. Defined Benefit
Plans

 

Non-U.S. Defined Benefit
Plans

 

Other Postretirement
Benefit Plans

 

Six Months Ended June 30,

 

2004

 

2003

 

2004

 

2003

 

2004

 

2003

 

Service Cost

 

$

4,835

 

$

4,472

 

$

2,877

 

$

2,545

 

$

78

 

$

237

 

Interest Cost

 

4,477

 

3,697

 

4,687

 

3,893

 

1,490

 

1,988

 

Expected return on plan assets

 

(4,897

)

(4,891

)

(4,821

)

(4,721

)

 

 

Amortization and deferrals:

 

 

 

 

 

 

 

 

 

 

 

 

 

Transition obligation (asset)

 

(21

)

(128

)

(169

)

(148

)

 

72

 

Actuarial Loss

 

1,575

 

391

 

953

 

110

 

574

 

271

 

Prior service cost (benefit)

 

359

 

331

 

 

 

(598

)

 

Special Termination Benefits

 

 

71

 

 

 

 

 

 

 

$

6,328

 

$

3,943

 

$

3,527

 

$

1,679

 

$

1,544

 

$

2,568

 

 

 

 

U.S. Defined Benefit
Plans

 

Non-U.S. Defined Benefit
Plans

 

Other Postretirement
Benefit Plans

 

Three Months Ended June 30,

 

2004

 

2003

 

2004

 

2003

 

2004

 

2003

 

Service Cost

 

$

2,417

 

$

2,050

 

$

1,428

 

$

1,269

 

$

39

 

$

118

 

Interest Cost

 

2,239

 

1,873

 

2,326

 

1,941

 

745

 

994

 

Expected return on plan assets

 

(2,449

)

(2,501

)

(2,393

)

(2,354

)

 

 

Amortization and deferrals:

 

 

 

 

 

 

 

 

 

 

 

 

 

Transition obligation (asset)

 

(10

)

(64

)

(84

)

(74

)

 

36

 

Actuarial Loss

 

788

 

152

 

473

 

55

 

287

 

135

 

Prior service cost (benefit)

 

180

 

150

 

 

 

(299

)

 

Special Termination Benefits

 

 

 

 

 

 

 

 

 

$

3,165

 

$

1,660

 

$

1,750

 

$

837

 

$

772

 

$

1,283

 

 

During the six months ended June 30, 2004, the Company contributed approximately $8.3 million to its pension and other postretirement benefit plans, comprising $1.0 million in benefits paid pertaining to unfunded U.S. defined benefit plans, $1.5 million in matching contributions to its 401(k) plan, $3.4 million in contributions to its foreign pension plans, and $2.4 million in benefits paid pertaining to its other postretirement benefits plans. The Company presently anticipates contributing an additional $7.7 million to these plans during the remainder of 2004, of which $1.0 million relates to benefit payments on its unfunded U.S. defined benefit plans, $1.3 million in matching contributions to its 401(k) plan, $3.4 million in contributions to its foreign pension plans and $2.0 million in benefit payments pertaining to its other postretirement benefit plans.

 

In December, 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the “Act”) was passed into law. The Act introduces a prescription drug benefit under Medicare Part D and a federal subsidy to sponsors of postretirement health care plans that provide a prescription drug benefit that is at least actuarially equivalent to Medicare Part D. The Company elected to defer accounting for the effects of the Act on the Company’s postretirement healthcare plans. Accordingly, as of June 30, 2004, any measures of the APBO or net periodic postretirement benefit cost in the Company’s consolidated financial statements do not reflect the effects of the Act.

 

12



 

15.                   Recent Accounting Pronouncements

 

In May 2004, the Financial Accounting Standards Board (“FASB”) issued FASB Staff Position (“FSP”) FAS 106-2, “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003” (the “Act”). This FSP supercedes FSP FAS No. 106-1, “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003”.

 

FSP FAS 106-2 provides guidance on accounting for the effects of the Act for employers that sponsor postretirement health care plans that provide drug benefits. The FSP also requires those employers to provide certain disclosures regarding the effect of the federal subsidy provided by the Act. The FSP becomes effective for the Company in the third quarter of 2004.  In the first interim and annual financial statements in which the employer includes the effects of the Act in measuring net periodic postretirement benefit costs or the Accumulated Benefit Plan Obligation (“APBO”), the following disclosures are required.

 

                  The reduction in the APBO related to the subsidy provided by the Act.

                  The effect of the subsidy on the measurement of net periodic postretirement benefit cost for the current period, including the effects related to amortization of the actuarial gain, the reduction in current period service cost due to the subsidy, and the reduction interest cost on the APBO resulting from the subsidy.

                  An explanation of any significant change in the benefit obligation not otherwise apparent in the disclosure required the FSP.

 

The Company elected to defer accounting for the effects of the Act on the Company’s postretirement healthcare plans. Accordingly, as of June 30, 2004, any measures of the APBO or net periodic postretirement benefit cost in the Company’s consolidated financial statements do not reflect the effects of the Act.

 

In March 2004, the Emerging Issues Task Force (“EITF”) reached a consensus on Issue No. 03-1, “The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments.” EITF 03-1 provides guidance on other-than-temporary impairment models for marketable debt and equity securities accounted for under SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities,” and SFAS No. 124, “Accounting for Certain Investments Held by Not-for-Profit Organizations,” and non-marketable equity securities accounted for under the cost method. The EITF developed a basic three-step model to evaluate whether an investment is other-than-temporarily impaired. The provisions of EITF 03-1 will be effective for the Company in the third quarter of fiscal 2004, and will be applied prospectively to all current and future investments. Quantitative and qualitative disclosures for investments accounted for under SFAS No. 115 are effective for the Company’s year ending December 31, 2004. The Company does not expect the adoption of EITF 03-1 to have a material effect on its consolidated financial statements.

 

In December 2003, the FASB issued SFAS No. 132 (revised 2003), “Employer’s Disclosures about Pensions and Other Postretirement Benefits.” The revised statement retains the disclosure requirements contained in SFAS No. 132, which it replaces, and requires additional disclosures about the assets, obligations, cash flows and net periodic benefit cost of defined benefit pension plans and other defined benefit postretirement plans. Except as noted below, the provisions of this statement are effective for the Company’s financial statements for the year ended December 31, 2003. The interim period disclosure requirements of the statement became effective for the Company’s interim financial statements for the quarter ending March 31, 2004, and are included Note 14. The statement’s disclosure requirements relating to estimated future benefit payments and relating to foreign plans are effective for the Company’s financial statements for the year ending December 31, 2004.

 

13



 

ITEM 2.          MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview

 

UNOVA, Inc. (the “Company”) is a global technology company providing customers with integrated solutions for improving their efficiency and productivity. The Company earns revenues from the sale of products, technologies, solutions and services to businesses.

 

The Company has two reportable segments, Automated Data Systems (“ADS”) and Industrial Automation Systems (“IAS”). The ADS segment comprises the Company’s wholly owned subsidiary Intermec Technologies Corporation. Intermec products and services include rugged mobile computing solutions, wireless, radio frequency identification (RFID) and automated data collection systems for field, on-premises, and site-based workers as well as wireless network systems for untethered enablement of an enterprise, and barcode label and printing solutions. ADS’s rugged and robust systems, solutions and services enable Intermec customers to more efficiently and effectively manage their supply chains and fulfillment activities. The IAS segment, comprising the Cincinnati Lamb division and the Landis Grinding Systems division, is a leading producer of value-added manufacturing products and services spanning the production cycle from process engineering and design to systems integration including comprehensive life cycle support. IAS serves the global aerospace, automotive, off-road vehicle and diesel engine industries as well as the industrial components, heavy equipment and general job shop markets.

 

The Company’s strategy revolves around continued investment in technology, intellectual property, research and development and innovation; expanding and strengthening the product portfolio; providing integrated solutions; partnering with global industry leaders; delivering value to customers and working to reduce costs and improve profitability, market share and strength.  The technology and innovation for which the Company focuses its research and development efforts are related to developing products, processes and services that help improve productivity, efficiency, information and controls in a variety of manufacturing, distribution, retail, field service and logistics supply chain applications. All the Company’s businesses offer integrated solutions as well as single products to their customers.  Future growth in these businesses is expected to primarily result from expansion of the Company’s existing operations and customer base. The Company’s financial strength and ability to adapt to the current market and economic conditions are dependent in part on the generation of cash flow, effective management of working capital, funding commitments and other obligations, as well as the growth of the business.

 

14



 

Results of Operations

 

The following discussion compares the Company’s results of operations for the six and three months ended June 30, 2004 and 2003. Results from continuing operations exclude the operating results of Lamb Body & Assembly, classified as discontinued operations. Results of operations in millions of dollars and as a percentage of revenues were as follows:

 

 

 

Six Months Ended June 30,

 

Three Months Ended June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales and Service Revenues

 

$

601.9

 

 

 

$

543.7

 

 

 

$

304.2

 

 

 

$

279.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales and service

 

402.2

 

66.8

%

379.4

 

69.8

%

207.3

 

68.1

%

192.2

 

68.7

%

Selling, general and administrative

 

158.1

 

26.3

%

149.6

 

27.5

%

79.4

 

26.1

%

73.3

 

26.2

%

Depreciation and amortization

 

9.4

 

1.6

%

13.4

 

2.5

%

4.6

 

1.5

%

6.6

 

2.4

%

Special charges

 

0.6

 

0.1

%

1.9

 

0.3

%

0.2

 

0.1

%

0.9

 

0.3

%

Total Costs and Expenses

 

570.3

 

94.7

%

544.3

 

100.1

%

291.5

 

95.8

%

273.0

 

97.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Profit (Loss) from Continuing Operations

 

31.6

 

5.3

%

(0.6

)

(0.1

)%

12.7

 

4.2

%

6.7

 

2.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest, net

 

(6.3

)

(1.0

)%

(7.0

)

(1.3

)%

(3.2

)

(1.1

)%

(3.2

)

(1.1

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (Loss) from Continuing Operations before Income Taxes

 

25.3

 

4.2

%

(7.6

)

(1.4

)%

9.5

 

3.1

%

3.5

 

1.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Provision for Income Taxes

 

(9.1

)

(1.5

)%

(4.2

)

(0.8

)%

(3.8

)

(1.2

)%

(2.6

)

(0.9

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (Loss) from Continuing Operations, net of tax

 

16.2

 

2.7

%

(11.8

)

(2.2

)%

5.7

 

1.9

%

0.9

 

0.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from Discontinued Operations

 

(0.1

)

(0.0

)%

(3.9

)

(0.7

)%

(0.1

)

(0.0

)%

(1.7

)

(0.6

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Earnings (Loss)

 

$

16.1

 

2.7

%

$

(15.7

)

(2.9

)%

$

5.6

 

1.8

%

$

(0.8

)

(0.3

)%

 

Sales and Service Revenues

 

Total revenues for the six months ended June 30, 2004, were $601.9 million, an increase of $58.2 million, or 10.7%, compared with the corresponding prior year period. Total revenues for the three months ended June 30, 2004, were $304.2 million, an increase of $24.5 million, or 8.8%, compared with the corresponding prior year period. During the first quarter of 2004, and the second quarter of 2003, the Company received compensation related to settlements regarding certain of its intellectual property (“IP settlements”), which resulted in a significant, positive impact on the Company’s revenues and results of operations for the six months ended June 30, 2004, and the six and three months ended June 30, 2003. During the six months ended June 30, 2004, products and service revenue increased approximately $45.7 million, or 8.5%, compared with the corresponding prior year period as a result of revenue increases of  7.5% and 10.2% in the ADS and IAS segments, respectively. The related products and service operating profit increased $16.1 million from the prior year comparable period due to increases of $1.9 million and $14.2 million in the ADS and IAS segments, respectively. During the three months ended June 30, 2004, products and service revenue increased approximately $31.7 million, or 11.6%, compared with the corresponding prior year period as a result of revenue increases of 8.6% and 16.9% in the ADS and IAS segments, respectively. The related product and service operating profit increase of $10.7 million from the prior year comparable period reflects an improvement of $11.2 million in the IAS segment, partially offset by a decrease of $0.5 million in the ADS segment.

 

15



 

Costs and Expenses

 

Cost of sales and service increased $22.8 million, or 6.0%, to $402.2 million for the six months ended June 30, 2004, from $379.4 million for the six months ended June 30, 2003, and $15.1 million, or 7.9%, to $207.3 million for the three months ended June 30, 2004, from $192.2 million for the three months ended June 30, 2003. Cost of sales and service as a percentage of sales decreased to 66.8% and 68.1% for the six and three months ended June 30, 2004, respectively, compared with 69.8% and 68.7% for the comparable prior year periods. The improvement in gross margin for the six months ended June 30, 2004, was primarily due to a 2.2 percentage point improvement in ADS product and service gross margins, the impact of IP settlements and a 2.6 percentage point improvement in IAS gross margins in 2004. The improvement in gross margin for the three months ended June 30, 2004, was primarily due to a 1.4 percentage point improvement in ADS gross margins and a 4.8 percentage point improvement in IAS gross margins.

 

Selling, General and Administrative

 

Selling, general and administrative (“SG&A”) expenses were $158.1 million and $79.4 million for the six and three months ended June 30, 2004, respectively, compared with SG&A expenses of $149.6 million and $73.3 million for the corresponding prior year period. SG&A as a percentage of sales was 26.3% and 27.5% for the six months ended June 30 2004, and 2003, respectively, and 26.1% and 26.2% for the three months ended June 30, 2004, and 2003, respectively. The six-month increase of $8.5 million from the prior year period is primarily due to a $9.5 million increase in ADS research and development (“R&D”) expense and a $2.3 million increase in SG&A expense due to the growth in ADS products and service revenues. The increase in SG&A expense within ADS was partially offset by the efficiencies resulting from the IAS restructuring and a $2.8 million reduction in corporate and other unallocated expenses resulting from the absence of loan termination expense, a favorable litigation outcome and the cost benefits received from transitioning the corporate headquarters to Everett.  The $6.1 million increase in SG&A in the three months ended June 30, 2004, compared to the prior year period was primarily due to a ADS incremental R&D spending of $5.1 million and increased spending corresponding to increased product and service revenues partially offset by the effect of the IAS restructuring.

 

Depreciation and Amortization

 

Depreciation and amortization expense for the six and three months ended June 30, 2004, were $9.4 million and $4.6 million, respectively, compared with $13.4 million and $6.6 million for the corresponding prior year periods. The decrease in depreciation and amortization expense of $4.0 million and $2.0 million for the six and three months ended June 30, 2004, respectively, from the corresponding prior year periods is primarily due to lower property, plant and equipment (“PP&E”) balances. The decrease in the PP&E balance primarily relates to the IAS restructuring which included the sale of assets, asset impairment and during the third quarter of 2003 PP&E with a net book value of $30.0 million was reclassified to assets held for sale, eliminating depreciation on those assets.

 

Special Charges

 

The following table sets forth the charges relating to the Company’s restructuring activities, comprising severance, facility consolidation, and impairment of PP&E, classified as special charges on the consolidated statements of operations (millions of dollars):

 

16



 

 

 

Six Months Ended
June 30,

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

IAS:

 

 

 

 

 

 

 

 

 

Facility consolidation

 

$

0.1

 

$

0.7

 

$

(0.1

)

$

0.6

 

Impairment of property, plant and equipment

 

0.1

 

 

 

 

Severance

 

 

0.6

 

 

 

Total IAS

 

0.2

 

1.3

 

(0.1

)

0.6

 

 

 

 

 

 

 

 

 

 

 

Corporate:

 

 

 

 

 

 

 

 

 

Facility consolidation

 

0.4

 

0.6

 

0.4

 

0.3

 

Total Corporate

 

0.4

 

0.6

 

0.4

 

0.3

 

Special charges

 

$

0.6

 

$

1.9

 

$

0.3

 

$

0.9

 

 

IAS Segment: In the fourth quarter of 2002, as a result of the continued economic downturn in the global automotive, aerospace and heavy equipment industries, the Company initiated a plan to consolidate its Cincinnati Machine, Lamb Machining Systems and Lamb Body & Assembly Systems divisions into the new operating entity, Cincinnati Lamb. The plan included the relocation of certain Cincinnati Machine operations, outsourcing of certain manufacturing activities, termination of employees, and the sale of certain plant and equipment. This restructuring was substantially complete by December 31, 2003.

 

During the six months ended June 30, 2004, IAS recorded additional charges of $0.2 million for additional facility consolidation costs and $0.1 million for impairment of property, plant and equipment in conjunction with this plan. As of June 30, 2004, the IAS segment had terminated 793 employees and paid $20.0 million in severance, cumulatively, in conjunction with this plan. During the six months ended June 30, 2004, 109 employees were terminated and $3.7 million of severance was paid in conjunction with this plan. The number of employees terminated does not include 228 employees of Lamb Body & Assembly that are no longer IAS employees as a result of the divestiture of this operation in September 2003.

 

Corporate: During the third quarter 2002, the Company initiated a plan to relocate its corporate office to its existing Intermec Technologies Corporation facility in Everett, Washington. This relocation was substantially complete by June 30, 2003. As of June 30, 2004, 22 employees had been terminated and $0.7 million in severance costs had been paid, cumulatively, of which 2 employee terminations and $0.3 million in severance payments occurred during the six months ended June 30, 2004. In the first quarter of 2004, $1.4 million of the workforce reduction accrual, relating to certain pension obligations for certain individuals affected by the restructuring plan, was reclassified to other long-term liabilities. The corporate restructuring accrual of $2.0 million as of June 30, 2004, relates to ongoing leased facility obligations. During the six months ended June 30, 2004, $1.0 million of leased facility costs were paid and during the three and six months ended June 30, 2004, the Company recognized $0.4 million of expense related to ongoing leased facility obligations.

 

17



 

Interest, Net

 

Net interest expense was $6.3 million and $3.2 million for the six and three months ended June 30, 2004, respectively, compared with $7.0 million and $3.2 million for the corresponding prior year periods, reflecting lower average debt in the six months ended June 30, 2004, and higher cash and cash equivalent balances during the six and three month periods ended June 30, 2004, compared to the corresponding prior year periods. In January 2003, the Company fully paid down and terminated the remaining $16.2 million balance of a term loan.

 

Provision for Income Taxes

 

The provision for income taxes for the six and three months ended June 30, 2004, is primarily related to federal, state and foreign taxes. The effective income tax rate for the six and three months ended June 30, 2004, was 36% and 40%, respectively. The effective income tax rate for the six months ended June 30, 2004, was lower than the normal effective tax rate of 38% to 40% due to the recognition of certain previously unrecognized state income tax loss carryforwards in the first quarter 2004. The provision for income taxes for the six and three months ended June 30, 2003, is primarily related to foreign and state taxes, as the domestic tax benefit was offset by a corresponding valuation allowance.

 

Loss from Discontinued Operations

 

During the third quarter 2003, in conjunction with the consolidation plan described in Note 5, the Company sold substantially all the assets and existing backlog of its Lamb Body & Assembly Systems division. The Company received $12.8 million in 2003, and $2.5 million in April 2004, and retained $9.9 million in accounts payable. The division meets the definition of a “component of an entity” and has been accounted for as a discontinued operation under Statement of Financial Accounting Standards No. 144 (“SFAS No. 144”), “Accounting for the Impairment or Disposal of Long-Lived Assets.” The Company’s consolidated statement of operations for the six and three month periods ended June 30, 2003, have been restated to present this division as discontinued operations for comparative purposes.

 

Sales and service revenue from discontinued operations for the six and three month periods ended June 30, 2004, were $0.9 million and $0.9 million, respectively, compared with $22.1 million and $12.4 million for the corresponding prior year period. Losses from discontinued operations were $0.1 million and $0.1 million for the six and three months ended June 30, 2004. The related tax effect from discontinued operations for the six and three months ended June 30, 2004, was not material. Losses from discontinued operations were $3.9 million and $1.7 million for the six and three months ended June 30, 2003. Losses from discontinued operations did not have a tax effect for the six and three months ended June 30, 2003, as the Company’s domestic income tax benefit was offset by a corresponding valuation allowance.

 

18



 

Segment Information

 

The following table sets forth sales and service revenues, segment operating profit and operating profit (loss) from continuing operations for the six and three month periods ended June 30, 2004,and 2003 (millions of dollars):

 

 

 

Six Months Ended
June 30,

 

Three Months Ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

 

 

 

 

 

 

 

 

 

 

Sales and Service Revenues

 

 

 

 

 

 

 

 

 

Automated Data Systems

 

$

379.6

 

$

341.9

 

$

186.6

 

$

179.0

 

Industrial Automation Systems

 

222.3

 

201.8

 

117.6

 

100.7

 

Total Sales and Service Revenues

 

$

601.9

 

$

543.7

 

$

304.2

 

$

279.7

 

 

 

 

 

 

 

 

 

 

 

Operating Profit (Loss) from Continuing Operations

 

 

 

 

 

 

 

 

 

Segment Operating Profit (Loss)

 

 

 

 

 

 

 

 

 

Automated Data Systems

 

$

43.6

 

$

30.5

 

$

15.6

 

$

21.5

 

Industrial Automation Systems

 

(2.2

)

(16.5

)

3.0

 

(8.2

)

Total Segment Operating Profit

 

41.4

 

14.0

 

18.6

 

13.3

 

 

 

 

 

 

 

 

 

 

 

Corporate and Other

 

(9.2

)

(12.7

)

(5.7

)

(5.7

)

Special Charges

 

(0.6

)

(1.9

)

(0.2

)

(0.9

)

Operating Profit from Continuing Operations

 

$

31.6

 

$

(0.6

)

$

12.7

 

$

6.7

 

 

 

Automated Data Systems

 

ADS segment revenues for the six and three month periods ended June 30, 2004, were $379.6 million and $186.6 million, respectively, representing increases of 11.0% and 4.2% from revenues of $341.9 million and $179.0 million for the same periods in 2003. The six months ended June 30, 2004, and 2003, include significant revenue and operating profit related to IP settlements. The specific terms of the settlement are confidential. For the six months ended June 30, 2004, and 2003, the IP settlement, net of legal fees, resulted in a favorable impact on segment operating profit of $15.8 million and $4.6 million, respectively.  For the three months ended June 30, 2003, IP settlements, net of legal fees provided $5.3 million in segment operating profit.

 

ADS product and service revenue for the six and three months ended June 30, 2004, increased 7.5% and 8.5%, respectively, from the prior year comparable period. For the three months ended June 30, 2004, systems and solutions revenues increased by 15.2%, printer/media increased by 0.9% and service increased by 1.7% over the corresponding prior year period. Geographically, product and service revenue for EMEA increased 5.4%, North America increased 8.6%, Asia Pacific increased 30.6% and Latin America increased 10.0% compared to the corresponding prior year period. The revenue increase in North America reflects improved performance in the region’s indirect sales channels and continued enhancement of product lines which allow greater sales traction with existing and new partners. EMEA revenues comprise a broader customer base in contrast to the corresponding prior year period, which included significant large shipments. The revenue increase in the Asia Pacific region is due to broader expansion throughout the region. The revenue increase in Latin America was primarily due to direct store delivery applications.  For the six and three months ended June 30, 2004, favorable foreign exchange rates contributed approximately $14.0 million and $5.1 million of the revenue increase compared to the related prior year periods.

 

For the six and three months ended June 30, 2004, ADS reported operating profit from product and service revenue of $27.9 million and $15.6 million, respectively, compared with operating profit of $25.9 million and $16.2 million in the corresponding prior year period. The operating profits in 2004 primarily reflect the impact of additional gross profits from the increases in product and service revenues, as well as the effect of gross margin improvement of 2.2 and 1.4 percentage points for the six and three months ended June 30, 2004 from the comparable prior year periods, increased R&D spending of $9.5 million and $5.1 million, respectively, and the incremental selling, marketing and other SG&A expenses.

 

19



 

An additional patent infringement lawsuit regarding the Company’s battery power-management patents is pending and may result in future revenue.  Settlements have been reached to date with companies that in the aggregate represent approximately ninety percent of U.S. laptop sales. Management cannot predict the outcome, timing or amount of future settlements or judgments.

 

Industrial Automation Systems

 

IAS segment revenues from continuing operations increased $20.5 million, or 10.2%, and $17.0 million, or 16.9%, for the six and three month periods ended June 30, 2004, respectively, compared with the corresponding prior year periods. IAS operating losses for the six months ended June 30, 2004, and 2003, were $2.2 million and $16.4 million, respectively. IAS operating income for the three months ended June 30, 2004, was $3.0 million, compared with operating losses of $8.2 million for the same period in 2003. The favorable comparisons are primarily due to improvements in the Cincinnati Lamb business, the lower breakeven levels resulting from the merger of these divisions and a $0.7 million gain on the sale of a facility which was classified in assets held for sale.  Additionally, order rates for the IAS aftermarket parts and service business returned to their highest level since the September 11th tragedy in 2001.

 

Backlog for the IAS segment was $268.2 million at June 30, 2004, compared with $266.1 million at December 31, 2003, adjusted to exclude discontinued operations. In the second quarter of 2004, IAS bookings were $138.7 million compared to bookings in the range of $85 million to $106 million in the preceding three quarters.  This increase was primarily due to the segment receiving its first large orders for machines in China and continuing to experience strong demand for retool programs in North America.

 

The six and three month periods ended June 30, 2004, and 2003, include special charges resulting from the IAS segment’s cost reduction actions including consolidation of plant facilities, sale or closure of certain underperforming operations and the consolidation of the Cincinnati Machine and the Lamb Machining Systems operations. See the discussion above under the heading “Special Charges.”

 

Corporate and Other

 

Operating expenses from Corporate and Other were $9.2 million and $5.7 million for the six and three months ended June 30, 2004, respectively, compared with operating expenses of $12.7 million and $5.7 million for the same periods in 2003. The decrease in expense of $3.5 million was primarily due to cost reductions from the relocation of corporate headquarters to Everett, Washington in 2003, a favorable ruling in an IP legal dispute during the first quarter of 2004 and a $0.5 million reduction in currency losses, compared to the comparable prior year period, partially offset by $1.2 million in 2004 costs related to Sarbanes Oxley 404 compliance activities.

 

Expectations

 

During its quarterly conference call on July 26, 2004, the Company provided projections of segment revenues and operating profit for the third quarter of 2004, as discussed below.  The Company cannot ensure that such projections will be realized as future results may be affected by numerous uncertainties, many of which are described in the section below captioned “Forward-Looking Statements and Risk Factors.”

 

ADS products and service revenues for the third quarter of 2004, are expected to be in the range of $187 to $192 million, reflecting a projected increase in the range of 12% to 15% over the corresponding prior year quarter. The related operating profit is expected to be in the range of $12 to $14 million.

 

The IAS segment revenues for the third quarter of 2004, are expected to be in the range of $120 to $130 million and there is expected to be a higher mix of lower margin business than originally anticipated.  The related operating loss is expected to be in the range of $2 to $3 million.

 

20



 

Liquidity and Capital Resources

 

The Company’s cash and cash equivalent position as of June 30, 2004, was $191.1 million, a decrease of $47.3 million compared to the December 31, 2003 balance. Long-term obligations decreased from $208.5 million at December 31, 2003, to $108.5 million at June 30, 2004, due to the reclassification to current portion of long-term obligations of $100 million which mature in March 2005.

 

Cash used in operating activities of $49.5 million was due primarily to $7.0 million in bond interest paid and $42.5 million used by operations. Cash provided by the ADS segment, primarily from IP settlement proceeds, was more than offset by cash used by the IAS segment of $56.0 million, primarily related to the working capital requirements in the early build cycle in certain long-term contracts. These working capital requirements are evidenced by growth in the Company’s accounts receivable and inventory levels. Accounts receivable increased $45.1 million, or 16%, to $320.7 million at June 30, 2004, reflecting the IAS segment’s early build-cycle in long-term contracts; and inventory increased $25.6 million, or 19%, to $157.9 million at June 30 2004, compared to December 31, 2003, reflecting the IAS early build cycle in long-term contracts and a buildup of ADS inventory levels due to new products. Investing activities used $2.1 million, primarily due to $6.4 million in capital expenditures, which was offset by $4.4 million in proceeds from sales of property and equipment and assets held for sale. Financing activities provided $4.2 million from stock option exercises and stock issued under the Employee Stock Purchase Plan.

 

The Company maintains two secured long-term credit facilities: a $100 million asset-based revolving credit facility (the “Revolving Facility”) and a £15.0 million ($27.4 million) revolving facility and related overdraft facility (collectively, the “UK Facility”).

 

The Company had borrowing capacity at June 30, 2004, of $21.6 million under the Revolving Facility and £6.9 million ($12.5 million) under the UK Facility, net of outstanding letters of credit and limitations on Minimum Availability. The Company had no borrowings under the Revolving Facility or the UK Facility at any time during the six months ended June 30, 2004. As of June 30, 2004, the Company was in compliance with the financial covenants of each of these agreements. As of March 31, 2004, the Revolving Facility was amended to provide greater flexibility for the Company to, among other things, change the organizational structure of Intermec Technologies Corporation, acquire or create additional subsidiaries in connection with stock or asset purchases, recapitalize certain subsidiaries, prepay or repurchase certain debt and increase the amount of cash and cash equivalents that can be pledged to secure certain external agreements. On July 9, 2004, the Revolving Facility was amended to extend its termination date to October 8, 2004.

 

In March 1998, the Company sold $200.0 million principal amount of senior unsecured debt in an underwritten offering. The debt comprised $100.0 million of 6.875% seven-year notes and $100.0 million of 7.00% ten-year notes. Interest payments are due semi-annually. Including underwriting fees, discounts and other issuance costs, the effective interest rates on the seven-year and ten-year notes are 7.125% and 7.175%, respectively. As of June 30, 2004, the $100.0 million seven-year notes, maturing in March 2005, are classified as current portion of long-term obligations on the Company’s consolidated balance sheet.

 

The Company additionally has outstanding $8.5 million of 3.21% industrial revenue bonds, maturing in July 2005.

 

Management believes that cash and cash equivalents on hand combined with projected cash flow from operations will provide adequate funding to meet its expected working capital and capital expenditure requirements for the next twelve months and the repayment of $100 million in bonds, maturing in March 2005. Projected cash flows from operations are largely based on the Company’s revenue estimates, cost estimates, and the related timing of cash receipts and cash disbursements. If actual performance differs from estimated performance, cash flow from operations could be positively or negatively impacted. Additional sources of liquidity for the Company include the Revolving Facility and the UK Facility.

 

21



 

Contractual Obligations

 

The Company’s contractual commitments as of June 30, 2004, have not changed materially from those disclosed in Item 7 of the Company’s annual report on Form 10-K for the year ended December 31, 2003.

 

Critical Accounting Policies

 

“Management’s Discussion and Analysis of Financial Condition and Results of Operations” discusses the Company’s consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual amounts could differ from those estimates under different assumptions or conditions. Management’s beliefs regarding significant accounting policies have not changed significantly from those disclosed in Item 7 of the Company’s annual report on Form 10-K for the year ended December 31, 2003.

 

New Accounting Pronouncements

 

In May 2004, the Financial Accounting Standards Board (“FASB”) issued FASB Staff Position (“FSP”) FAS 106-2, “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003” (the “Act”). This FSP supercedes FSP FAS No. 106-1, “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug, Improvement and Modernization Act of 2003”.

 

FSP FAS 106-2 provides guidance on accounting for the effects of the Act for employers that sponsor postretirement health care plans that provide drug benefits. The FSP also requires those employers to provide certain disclosures regarding the effect of the federal subsidy provided by the Act. The FSP becomes effective for the Company in the third quarter of 2004.  In the first interim and annual financial statements in which the employer includes the effects of the Act in measuring net periodic postretirement benefit costs or the Accumulated Benefit Plan Obligation (“APBO”), the following disclosures are required.

 

                  The reduction in the APBO related to the subsidy provided by the Act.

                  The effect of the subsidy on the measurement of net periodic postretirement benefit cost for the current period, including the effects related to amortization of the actuarial gain, the reduction in current period service cost due to the subsidy, and the reduction interest cost on the APBO resulting from the subsidy.

                  An explanation of any significant change in the benefit obligation not otherwise apparent in the disclosure required by the FSP.

 

The Company elected to defer accounting for the effects of the Act on the Company’s postretirement healthcare plans. Accordingly, as of June 30, 2004, any measures of the APBO or net periodic postretirement benefit cost in the Company’s consolidated financial statements do not reflect the effects of the Act.

 

In March 2004, the Emerging Issues Task Force (“EITF”) reached a consensus on Issue No. 03-1, “The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments.” EITF 03-1 provides guidance on other-than-temporary impairment models for marketable debt and equity securities accounted for under SFAS No. 115, “Accounting for Certain Investments in Debt and Equity Securities,” and SFAS No. 124, “Accounting for Certain Investments Held by Not-for-Profit Organizations,” and non-marketable equity securities accounted for under the cost method. The EITF developed a basic three-step model to evaluate whether an investment is other-than-temporarily impaired. The provisions of EITF 03-1 will be effective for the Company in the third quarter of fiscal 2004 and will be applied prospectively to all current and future investments. Quantitative and qualitative disclosures for investments accounted for under SFAS No. 115 are effective for the Company’s year ending December 31, 2004. The Company does not expect the adoption of EITF 03-1 to have a material effect on its consolidated financial statements.

 

22



 

In December 2003, the FASB issued SFAS No. 132 (revised 2003), “Employer’s Disclosures about Pensions and Other Postretirement Benefits.” The revised statement retains the disclosure requirements contained in SFAS No. 132, which it replaces, and requires additional disclosures about the assets, obligations, cash flows and net periodic benefit cost of defined benefit pension plans and other defined benefit postretirement plans. Except as noted below, the provisions of this statement are effective for the Company’s financial statements for the year ended December 31, 2003. The interim period disclosure requirements of the statement became effective for the Company’s interim financial statements for the quarter ending March 31, 2004, and are included Note 14. The statement’s disclosure requirements relating to estimated future benefit payments and relating to foreign plans are effective for the Company’s financial statements for the year ending December 31, 2004.

 

Forward-Looking Statements and Risk Factors

 

All statements in this report that are not historical facts or that include such words as “expect,”  “project,” “estimate,” “believe,” “could,” “may” or “plan” or other similar words are forward-looking statements that the Company deems to be covered by and to qualify for the safe harbor protection of the Private Securities Litigation Reform Act of 1995 (alternatively: Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934). Forward-looking statements include, but are not limited to, statements about the following:

 

                  The Company’s anticipated segment revenues and operating profit;

 

                  The anticipated demand for the Company’s products and services;

 

                  Anticipated improvements of existing products and development of new products in the Company’s ADS segment;

 

                  The Company’s view of the short- and long-term outlook for and trends in the markets for the Company’s products and services;

 

                  The Company’s anticipated contributions to its pension and other postretirement benefit plans.

 

                  The Company’s ability to

 

                  meet its working capital and capital expenditure requirements;

 

                  achieve its goals with respect to revenues and cost savings in each of its segments;

 

                  successfully manage and complete large-scale industrial systems contracts for customers;

 

                  successfully obtain critical components for its products;

 

                  complete large-scale mobile computing installations;

 

Forward-looking statements are not guarantees of future performance. Several factors govern whether the Company will or can achieve any forward-looking statement made in this report. Any one of these factors could cause the Company’s actual results to differ materially from those discussed in a forward-looking statement. The Company outlines these risk factors in reports that it files with the SEC, in press releases and on its website, www.unova.com. Such risk factors include, but are not limited to:

 

                  Continued weakness in the automotive and aerospace markets could lead to reduced demand for the Company’s products.

 

                  Technological changes and consequent market shifts could adversely impact demand for the Company’s products and systems.

 

                  Some of the Company’s competitors have greater financial and other resources than the Company and, as a result, may be able to adapt more quickly to market trends or price declines.

 

                  If the Company is unable to obtain key components of its products from its current suppliers, the cost of manufacturing the Company’s products could increase, the Company might have to re-engineer some products, and delivery times of some of the Company’s products could be delayed.

 

23



 

                  Political instability outside of the U.S. and hostility against U.S. companies in foreign jurisdictions could adversely affect the Company’s international operations.

 

                  Changes in U.S. and foreign government regulations regarding radio emissions could adversely affect the Company’s ability to sell its ADS products or complete development of anticipated new products.

 

Readers should consider the foregoing risk factors in evaluating the Company’s ability to achieve expected results or objectives set forth in any forward-looking statement. In addition, readers should not place undue reliance on forward-looking statements in making investment decisions regarding the Company. The Company disclaims any obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is exposed to interest rate risk primarily from its short-term and long-term borrowings and to foreign exchange rate risk with respect to its foreign operations and from foreign currency transactions.

 

Due to its global operations, the Company’s cash flows and earnings are exposed to foreign exchange rate fluctuations. When appropriate, the Company may attempt to limit its exposure to changing foreign exchange rates by entering into short-term foreign currency exchange contracts. As of June 30, 2004, the Company held short-term contracts for the purpose of hedging foreign currency cash flows with an aggregate notional amount of $132.2 million.

 

Except as noted in the preceding paragraphs, as of June 30, 2004, there have been no material changes in information provided in Item 7A of the Company’s annual report on Form 10-K for the year ended December 31, 2003, which contains a complete discussion of the Company’s material exposures to interest rate and foreign exchange rate risks.

 

ITEM 4.  CONTROLS AND PROCEDURES

 

The Company’s management, including the Chief Executive Officer and the Chief Financial Officer, supervised and participated in an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, the Chief Executive Officer and the Chief Financial Officer concluded as of the Evaluation Date that the Company’s disclosure controls and procedures were effective such that the information required to be disclosed in the Company’s Securities and Exchange Commission (“SEC”) reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and is accumulated and communicated to Company management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

24



 

PART II.  OTHER INFORMATION

 

ITEM 2.          CHANGES IN SECURITIES, USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

(e)               Issuer Purchases of Equity Securities

 

 

 

(a) Total
Number of
Shares
Purchased

 

(b) Average
Price Paid per
Share

 

(c) Total Number of
Shares Purchased as Part
of Publicly Announced
Plans or Programs

 

(d) Maximum Number of
Shares (or Approximate
Dollar Value) that May Yet
Be Purchased Under the
Plans or Programs

 

April 1 to April 30, 2004

 

 

 

 

 

May 1 to May 31, 2004

 

11,783

 

$

17.30

 

 

 

June 1 to June 30, 2004

 

 

 

 

 

Total

 

11,783

 

$

17.30

 

 

 

 

The purchased shares indicated in the above table were surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock.  Additionally, in February 2004, the Company purchased 59,397 shares of Common Stock, at an average price per share of $21.39, comprising shares surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock and shares deemed surrendered to the Company to pay the exercise price and to satisfy tax withholding obligations in connection with the exercise of employee stock options.

 

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

(a)               The Company’s Annual Meeting of Shareholders was held on May 6, 2004.

 

(b)              At the Annual Meeting, Larry D. Brady, Joseph T. Casey and Allen J. Lauer were elected directors for three-year terms expiring on the date of the annual meeting in 2007.  The votes were as follows:

 

Director/Nominee

 

For

 

Withheld

 

Larry D. Brady

 

52,477,041

 

1,186,605

 

Joseph T. Casey

 

51,958,730

 

1,704,916

 

Allen J. Lauer

 

52,316,687

 

1,346,959

 

 

The terms of the following directors continued after the Annual Meeting:

 

Stephen E. Frank

 

Steven B. Sample

Claire W. Gargalli

 

William D. Walsh

Lydia H. Kennard

 

Larry D. Yost

 

(c)               Proposal 2, a Board proposal recommending adoption of the UNOVA, Inc. 2004 Omnibus Incentive Compensation Plan, was approved, with the following votes:

 

 

 

Number of Votes

 

% of Shares Present on
this Proposal

 

% of Shares
Outstanding

 

For

 

34,832,045

 

79.64

%

57.58

%

Against

 

7,837,021

 

17.92

%

12.95

%

Abstain

 

1,068,879

 

2.44

%

1.77

%

Broker non-votes

 

9,925,701

 

0.00

%

16.40

%

 

25



 

Proposal 3, a shareholder proposal requesting declassification of the Board of Directors, received the votes of a majority of the shares present on the proposal.

 

 

 

Number of Votes

 

% of Shares Present on
this Proposal

 

% of Shares
Outstanding

 

For

 

24,207,317

 

55.35

%

40.01

%

Against

 

19,293,724

 

44.11

%

31.89

%

Abstain

 

236,902

 

0.54

%

0.39

%

Broker non-votes

 

9,925,703

 

0.00

%

16.40

%

 

ITEM 6.                               EXHIBITS AND REPORTS ON FORM 8-K

 

(a)                        Exhibits:

 

10.1

 

UNOVA, Inc. 2004 Omnibus Incentive Compensation Plan, filed as Appendix C to the Company’s definitive Proxy Statement relating to the Annual Meeting of Shareholder held on May 6, 2004, and incorporated herein by reference.

 

 

 

31.1

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated as of August 6, 2004.

 

 

 

31.2

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated as of August 6, 2004.

 

 

 

32.1

 

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated as of August 6, 2004.

 

 

 

32.2

 

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated as of August 6, 2004.

 

 

(b)                       Reports on Form 8-K:

 

On May 4, 2004, the Company filed a Form 8-K in regard to its press release announcing its financial results for the quarter ended March 31, 2004.

 

On July 26, the Company filed a Form 8-K in regard to its press release announcing the election of Gregory K. Hinckley to its Board of Directors and in regard to its press release announcing its financial results for the quarter ended June 30, 2004.

 

26



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

UNOVA, INC.

 

(Registrant)

 

 

 

 

 

By

/s/  Michael E. Keane

 

 

 

 

 

Michael E. Keane

 

 

Senior Vice President and

 

 

Chief Financial Officer

 

 

 

 

August 9, 2004

 

27